Barclays’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-9,304
| Closed | -$512K | – | 5019 |
|
|
2022
Q2 | $512K | Sell |
9,304
-13,196
| -59% | -$726K | ﹤0.01% | 2536 |
|
|
2022
Q1 | $721K | Buy |
+22,500
| New | +$721K | ﹤0.01% | 2550 |
|
|
2019
Q4 | – | Sell |
-3
| Closed | – | – | 4391 |
|
|
2019
Q3 | $0 | Sell |
3
-5
| -63% | – | ﹤0.01% | 4548 |
|
|
2019
Q2 | $0 | Buy |
+8
| New | – | ﹤0.01% | 4539 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4485 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4532 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4558 |
|
|
2018
Q2 | – | Sell |
-143
| Closed | -$12K | – | 4485 |
|
|
2018
Q1 | $12K | Buy |
143
+99
| +225% | +$8.31K | ﹤0.01% | 3931 |
|
|
2017
Q4 | $7K | Buy |
+44
| New | +$7K | ﹤0.01% | 3869 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4196 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 4164 |
|
|
2017
Q1 | – | Sell |
-135
| Closed | -$8K | – | 4214 |
|
|
2016
Q4 | $8K | Buy |
135
+103
| +322% | +$6.1K | ﹤0.01% | 3336 |
|
|
2016
Q3 | $2K | Sell |
32
-163
| -84% | -$10.2K | ﹤0.01% | 3653 |
|
|
2016
Q2 | $16K | Buy |
195
+190
| +3,800% | +$15.6K | ﹤0.01% | 2883 |
|
|
2016
Q1 | $1K | Sell |
5
-8
| -62% | -$1.6K | ﹤0.01% | 3365 |
|
|
2015
Q4 | $8K | Buy |
+13
| New | +$8K | ﹤0.01% | 2851 |
|